By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search

Company Profile


Pacira Pharmaceuticals, Inc. 

10450 Science Center Drive

San Diego  California  92121  U.S.A.
Phone: 858-625-2414 Fax: 858-678-3999



Company News
Pacira (PCRX) Announces Data Reinforcing Benefits Of EXPAREL For Postsurgical Pain Control Following Total Hip And Knee Replacement Surgery 3/26/2015 8:45:11 AM
Pacira (PCRX) Release: New Data Demonstrate Reduced Opioid Requirements Following Use Of EXPAREL In Hysterectomy And Mastectomy Procedures 3/24/2015 2:28:17 PM
Pacira (PCRX) To Present At The Barclays Global Healthcare Conference 3/5/2015 11:07:00 AM
Pacira Pharmaceuticals, Inc. (PCRX) Receives Complete Response Letter From FDA For sNDA Seeking Approval Of EXPAREL Use In Nerve Block To Provide Postsurgical Analgesia 3/2/2015 6:15:17 AM
Shares Fall as the FDA Rejects Pacira (PCRX)'s Application for Expanded Use of Pain Drug 3/2/2015 6:14:06 AM
Pacira Pharmaceuticals, Inc. (PCRX) Clears Up EXPAREL-Related FDA Warning Letter 2/11/2015 6:06:55 AM
Pacira Pharmaceuticals, Inc. (PCRX) To Host Analyst & Investor Day On Jan. 22 In New York 1/9/2015 9:42:04 AM
Pacira Pharmaceuticals, Inc. (PCRX) Reports Estimated Fourth Quarter Total Revenue Of $61.8 Million And Estimated Full-Year Total Revenue Of $197.7 Million 1/8/2015 2:03:37 PM
Pacira Pharmaceuticals, Inc. (PCRX) Announces Changes To EXPAREL┬« Label 12/12/2014 7:56:19 AM
Pacira Pharmaceuticals, Inc. (PCRX) To Present At The 26th Annual Piper Jaffray Healthcare Conference 11/25/2014 2:02:26 PM